Form 4: Procter & Gamble CEO Jon Moeller Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Jon Moeller, Chairman, President, and CEO of Procter & Gamble, exercised stock options and sold shares of common stock on August 9, 2024.
Summary
- On August 9, 2024, Jon R. Moeller, Chairman, President, and CEO of Procter & Gamble, exercised stock options to acquire 72,174 shares of common stock at a price of $98.55 per share.
- Simultaneously, Moeller sold 72,174 shares of Procter & Gamble common stock at a weighted average price of $171.0095, with prices ranging from $171.00 to $171.20.
- Following these transactions, Moeller directly owns 263,157.512 shares of Procter & Gamble common stock.
- Moeller also indirectly owns 23,347.6653 shares through retirement plan trustees and 35,421.5707 shares through his spouse.
- After the transaction, Moeller directly holds 87,979 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about executive compensation and ownership.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Large sales may sometimes raise concerns, while option exercises are generally viewed as a positive sign.
Comparison to Industry Standards
- Executive compensation practices, including stock options and share sales, are common across publicly traded companies.
- The specifics of these arrangements vary widely based on company size, industry, and individual performance.
- Comparing Moeller's transactions to those of CEOs at similar consumer goods companies (e.g., Unilever, Nestle, Colgate-Palmolive) would provide a more comprehensive understanding of the scale and context of these activities.
Stakeholder Impact
- Shareholders may be interested in these transactions as they reflect the CEO's view on the company's stock.
- The transactions themselves have a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/28/2022 | Date stock options were exercisable |
| 02/28/2029 | Expiration date of stock options |
| 08/09/2024 | Date of stock option exercise and share sale |
| 08/12/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.